Patrick Harter

Professor Patrick Harter is a faculty member at the Institute of Neuropathology, Ludwig Maximilian University of Munich (LMU), where he leads research in neuro-oncology and molecular diagnostics of CNS tumors. His work focuses on glioblastoma, meningioma, and brain metastasis, with emphasis on epigenetic mechanisms like DNA methylation and metabolic adaptations in the tumor microenvironment.

Research interests span:

• Molecular classification of brain tumors using DNA methylation profiling
• Therapeutic targeting of BRAF/MEK and PI3K/Akt/mTOR pathways
• Role of hypoxia and metabolic plasticity in treatment resistance
• Liquid biopsy development for non-invasive tumor monitoring

His recent publications demonstrate a strong trend toward integrating epigenetic, metabolic, and immunotherapeutic approaches. Articles frequently explore:

• Novel biomarkers for tumor grading and prognosis
• Mechanisms of therapy resistance in gliomas
• Impact of tumor microenvironment on metastasis